SCHEMBL3398883

SCHEMBL3398883

CC1(C(=O)Oc2ccc(Br)cc2)CCCCC1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FAAH O00519 1/20 0.42
TRPV1 Q8NER1 1/20 0.42
MAPT P10636 3/20 0.39
LMNA P02545 2/20 0.39
RAB9A P51151 2/20 0.39
MAPK1 P28482 2/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
RXFP1 Q9HBX9 1/20 0.39
OPRM1 P35372 1/20 0.38
OPRD1 P41143 1/20 0.38
CHRNA7 P36544 3/20 0.38
P2RX7 Q99572 1/20 0.37
NPC1 O15118 1/20 0.37
ATM Q13315 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
MGLL Q99685 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3392975 0.95 MAPT (0.40) FAAHTRPV1MAPTLMNARAB9A
SCHEMBL27807027 0.85 MAPT (0.50) MAPTLMNAMEN1KMT2AP2RX7
SCHEMBL8587643 0.85 FAAH (0.45) FAAHTRPV1MAPTLMNAMEN1
SCHEMBL27745498 0.83 KDM4E (0.49) FAAHTRPV1MAPTRAB9AP2RX7
SCHEMBL8586762 0.83 FAAH (0.43) FAAHTRPV1MAPTLMNAKMT2A
SCHEMBL27796546 0.81 L3MBTL1 (0.48) FAAHTRPV1MAPTRAB9AP2RX7
SCHEMBL8584103 0.76 KDM2B (0.46) MAPTLMNARAB9AMEN1KMT2A
SCHEMBL18259718 0.74 L3MBTL1 (0.51) MAPTMAPK1MEN1KMT2AATM
SCHEMBL2034770 0.73 CYP1A2 (0.50) FAAHTRPV1MAPTLMNAMEN1
SCHEMBL8585753 0.73 ALDH1A1 (0.44) MAPTLMNARAB9AKMT2ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100204119-A1 4-AMINO-5-OXO-7,8-DIHYDROPYRIMIDO[5,4-F][1,4]OXAZEPIN-6(5H)-YL PHENYL DERIVATIVES PFIZER INC 2010-08-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100204119-A1 4-AMINO-5-OXO-7,8-DIHYDROPYRIMIDO[5,4-F][1,4]OXAZEPIN-6(5H)-YL PHENYL DERIVATIVES DGAT1, DGAT2, MOGAT2 FAAH 222/4885TRPV1 2056/4885MAPT 1697/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.